LabCyte Wins $1M SBIR Grant to Continue Work with Stanford on MALDI-MS Protein Assays | GenomeWeb

Sample prep firm Labcyte said this week that it has received a $1 million Phase II small business innovation research grant for work on developing the company's acoustic liquid handling system as part of MALDI mass spec workflows.

The award, which follows a $196,000 Phase I SBIR grant the company received in November 2011, will fund a collaboration between Labcyte and researchers at Stanford University and the Fred Hutchinson Cancer Research Center exploring the use of MALDI mass spec for verification and validation of breast cancer biomarkers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.